drugset / Trial / NCT07070466
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
NaSingle-groupOpen-labelTreatment
Summary
This is a single arm, open-label, phase II trial investigating the combination of ivonescimab with standard FOLFOX chemotherapy in 1L therapy for HER2- GEA.
Timeline
- Start
- 2025-10-10
- Primary completion
- 2026-12-01
- Completion
- 2028-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | — | Intravenous |
| Background | Leucovorin | Small molecule | — | Intravenous |
| Background | Oxaliplatin | Small molecule | — | Intravenous |
| Background | fluorouracil | Small molecule | — | Intravenous |